Publication | Closed Access

The immunohistochemical overexpression of ribonucleotide reductase regulatory subunit M1 (RRM1) protein is a predictor of shorter survival to gemcitabine-based chemotherapy in advanced non-small cell lung cancer (NSCLC)

Tumor BiologyMedicineImmunohistochemical OverexpressionPathologyCancer GenomicsCancer BiologyGemcitabine-based ChemotherapyTumor SuppressorCancer TreatmentCancer GeneticsLung CancerOncologyCell BiologyTumor MicroenvironmentCancer ResearchShorter Survival